Key facts
- Notable investors include Lazio Innova, Turenne Groupe, Quadrivio Group, Muzinich & Co, BNP Paribas — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for MIR (Rome)
- ·The full record, as it builds
Funding rounds
No funding rounds for MIR (Rome) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MIR (Rome)
Manufacturer of pulmonary diagnostic devices intended to help facilitate more comprehensive personal health monitoring. The company offers a wide range of products that function as minilabs capable of performing both spirometry and oximetry, including new diagnostic processes for sleep apnea, and are connected wirelessly to a web-based platform with wireless data transmission, thereby enabling clients to avail of simple and cost-effective devices.
- Sector
- Healthcare
- HQ
- Rome, Italy
- Founded
- 1993
- Employees
- 106
- Website
- spirometry.com/
- Ownership
- Privately Held (backing)
MIR (Rome) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MIR (Rome) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MIR (Rome) in its N-PORT filings yet. We sweep new filings monthly.